WallStreetZenWallStreetZen

NASDAQ: ICAD
Icad Inc Earnings & Revenue

Open Broker Account

ICAD past revenue growth

How has ICAD's revenue growth performed historically?
Company
-19.35%
Industry
22.31%
Market
185.33%
ICAD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ICAD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ICAD's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ICAD earnings and revenue history

Current Revenue
$29.3M
Current Earnings
-$14.7M
Current Profit Margin
-50.3%

ICAD Return on Equity

Current Company
-34.8%
Current Industry
-29.8%
Current Market
-8.3%
ICAD's Return on Equity (-34.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ICAD announces earnings.

ICAD Return on Assets

Current Company
-25.1%
Current Industry
-9.6%
ICAD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ICAD Return on Capital Employed

Current Company
-36.03%
Current Industry
-14.3%
ICAD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ICAD vs Health Information Service Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ICAD$29.26M-$13.60M-$14.71M+1.53%N/A
AUGX$28.76M-$21.06M-$24.32M+34.50%N/A
MTBC$143.75M$25.06M-$6.85M+34.76%N/A
UPH$158.74M-$282.44M-$335.17M+216.88%N/A
EUDA$10.48M-$1.72M-$2.08M-100.00%N/A

Icad Earnings & Revenue FAQ

What were ICAD's earnings last quarter?

On Invalid Date, Icad (NASDAQ: ICAD) reported Q3 2022 earnings per share (EPS) of -$0.15, up 66.67% year over year. Total Icad earnings for the quarter were -$3.90 million. In the same quarter last year, Icad's earnings per share (EPS) was -$0.09.

If you're new to stock investing, here's how to buy Icad stock.

What was ICAD's earnings growth in the past year?

As of Q4 2022, Icad's earnings has grown year over year. Icad's earnings in the past year totalled -$14.71 million.

What was ICAD's revenue last quarter?

On Invalid Date, Icad (NASDAQ: ICAD) reported Q3 2022 revenue of $6.36 million up 32.1% year over year. In the same quarter last year, Icad's revenue was $9.36 million.

What was ICAD's revenue growth in the past year?

As of Q4 2022, Icad's revenue has grown -19.35% year over year. This is 41.66 percentage points lower than the US Health Information Services industry revenue growth rate of 22.31%. Icad's revenue in the past year totalled $29.26 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.